Deoxyhypusine hydroxylase as a novel pharmacological target for ischemic stroke via inducing a unique post-translational hypusination modification.
Guo Q, Zhang YC, Wang W, Wang YQ, Liu Y, Yang Z, Zhao MM, Feng N, Wang YH, Zhang XW, Yang H, Liu TT, Shi LY, Shi XM, Liu D, Tu PF, Zeng KW.
Guo Q, et al. Among authors: zeng kw.
Pharmacol Res. 2022 Feb;176:106046. doi: 10.1016/j.phrs.2021.106046. Epub 2022 Jan 7.
Pharmacol Res. 2022.
PMID: 35007708